Paeds Vivas · infectious-diseases
Cellulitis, abscess and necrotising soft-tissue infection: Viva
Branching clinical structured oral on paediatric skin and soft-tissue infection: distinguishing cellulitis, abscess, and necrotising infection, the purulent versus non-purulent decision, MRSA-aware antibiotic selection, and the time-critical surgical decision.
On this page
Study tools
Target exams
Branch 1: Classifying the infection and the purulent decision
The candidate should recognise that this child has both a purulent and a non-purulent element: a fluctuant abscess in the mid-forearm surrounded by a rim of cellulitis. The first decision, following the 2014 Infectious Diseases Society of America framework, is to separate purulent from non-purulent infection, because the therapy differs. The abscess is treated primarily by incision and drainage, while the surrounding cellulitis is treated with antibiotics directed at streptococci and staphylococci. [1]
The candidate should confirm the child is cardiovascularly stable and not toxic, which places her in the non-necrotising category for now, but should state explicitly the features that would trigger concern for necrotising infection: severe pain out of proportion to the visible erythema, systemic toxicity, tense woody induration, haemorrhagic bullae, crepitus, or rapid spread. The absence of these features in this child supports a purulent abscess with surrounding cellulitis rather than a surgical emergency. [3]
References3ShowHide
- [1]Stevens DL Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis, 2014.PMID 24947530
- [2]Sanders JE Evidence-based management of skin and soft-tissue infections in pediatric patients in the emergency department. Pediatr Emerg Med Pract, 2015.PMID 25682652
- [3]Hua C Necrotising soft-tissue infections. Lancet Infect Dis, 2023.PMID 36252579